- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07592338
Agreement Between Large Language Model-Generated Treatment Recommendations With Guideline-Based and Tumor Board Decisions in Gastrointestinal Cancer (KITuKo)
Concordance of Large Language Model-Generated Treatment Recommendations With Multidisciplinary Tumor Board and Guideline-Based Decisions in Gastrointestinal Cancer: A Retrospective Cohort Study
The goal of this observational study is to learn whether a computer program can suggest cancer treatments that match expert recommendations for people with gastrointestinal cancer (cancer of the pancreas, stomach, or colon and rectum).
The main questions it aims to answer are:
- Do the treatment suggestions from the computer program match current medical guidelines?
- Do these suggestions match decisions made by a multidisciplinary tumor board (a team of cancer specialists)?
Researchers will review existing medical records from people who have already been treated for these cancers. They will enter key clinical information into a computer program that uses artificial intelligence (AI). The program will generate treatment suggestions for each case.
Researchers will then compare these suggestions with:
- guideline-based treatment recommendations
- decisions made by the tumor board
This study will help researchers understand whether AI tools could support doctors in making cancer treatment decisions in the future.
Studie Overzicht
Toestand
Gedetailleerde beschrijving
Gastrointestinal cancers require complex treatment planning that often involves surgery, systemic therapy, and multidisciplinary coordination. Clinical decision-making is typically guided by evidence-based recommendations and discussed in multidisciplinary tumor boards. However, the increasing complexity of treatment strategies and guideline frameworks can make consistent and reproducible decision-making challenging in routine clinical practice.
Recent advances in artificial intelligence have enabled the development of large language models (LLMs) that can process structured clinical information and generate text-based recommendations. These systems may offer a scalable approach to support clinical workflows, but their ability to produce reliable and clinically appropriate treatment suggestions in oncology remains uncertain.
This study evaluates the performance of an LLM-based system in the context of gastrointestinal oncology using retrospectively collected clinical case data. Structured case summaries derived from routine clinical documentation are used as standardized input. The model generates treatment recommendations under controlled conditions, allowing systematic comparison with established clinical reference standards.
The analysis focuses on the level of agreement between model-generated recommendations and established decision-making frameworks. In addition, the study explores how model performance varies across different clinical scenarios, including varying levels of disease complexity. Particular attention is given to situations in which recommendations differ, in order to better understand potential limitations of the model and identify patterns that may be clinically relevant.
Furthermore, the study examines the consistency of model outputs when the same clinical information is processed multiple times. This provides insight into the stability and reproducibility of the system, which are important considerations for potential real-world use.
The findings of this study are intended to inform the potential role of LLM-based tools as supportive systems in clinical decision-making. The study does not evaluate clinical outcomes or patient benefit, but instead focuses on agreement with established standards and expert-driven decisions as an initial step in assessing feasibility and safety.
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
Brandenburg
-
Brandenburg an der Havel, Brandenburg, Duitsland, 14770
- University Hospital Brandenburg
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- Histologically confirmed pancreatic, gastric, or colorectal adenocarcinoma
- Treatment discussed in a multidisciplinary tumor board
Exclusion Criteria:
- Non-adenocarcinoma histology
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
|---|---|
|
Colorectale kanker
Patiënten met darmkanker
|
Detailed treatment recommendation according to the official guideline of the Association of the Scientific Medical Societies in Germany (AWMF; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften),
Structured clinical case summaries were analyzed by a GPT-4-class large language model to generate treatment recommendations.
Detailed treatment recommendation according to the case-specific postoperative tumor board review.
|
|
Pancreatic cancer
Patients with pancreatic cancer
|
Detailed treatment recommendation according to the official guideline of the Association of the Scientific Medical Societies in Germany (AWMF; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften),
Structured clinical case summaries were analyzed by a GPT-4-class large language model to generate treatment recommendations.
Detailed treatment recommendation according to the case-specific postoperative tumor board review.
|
|
Gastric cancer
Patients with gastric cancer
|
Detailed treatment recommendation according to the official guideline of the Association of the Scientific Medical Societies in Germany (AWMF; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften),
Structured clinical case summaries were analyzed by a GPT-4-class large language model to generate treatment recommendations.
Detailed treatment recommendation according to the case-specific postoperative tumor board review.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Concordance with guideline-based management
Tijdsspanne: At the time of multidisciplinary tumor board evaluation up to 4 weeks after surgery
|
Agreement between LLM-generated recommendations and AWMF guideline-supported treatment strategies
|
At the time of multidisciplinary tumor board evaluation up to 4 weeks after surgery
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Concordance with multidisciplinary tumor board decisions
Tijdsspanne: At the time of multidisciplinary tumor board evaluation up to 4 weeks after surgery
|
Agreement between LLM-generated recommendations and tumor board treatment strategies
|
At the time of multidisciplinary tumor board evaluation up to 4 weeks after surgery
|
|
Reproducibility of LLM recommendations across repeated runs
Tijdsspanne: At the time of multidisciplinary tumor board evaluation up to 4 weeks after surgery
|
Structured clinical case vignettes were entered into ChatGPT using a standardized prompt template.
To assess within-model reproducibility, each clinical vignette was analyzed in 3 independent model sessions performed on different days using identical clinical input.
|
At the time of multidisciplinary tumor board evaluation up to 4 weeks after surgery
|
|
Characterization of discordant recommendations (e.g., overtreatment, undertreatment)
Tijdsspanne: At the time of multidisciplinary tumor board evaluation up to 4 weeks after surgery
|
Overtreatment was defined as an LLM-generated recommendation exceeding the intensity of the reference recommendation. Undertreatment was defined as omission of a recommended treatment or recommendation of a less intensive strategy. |
At the time of multidisciplinary tumor board evaluation up to 4 weeks after surgery
|
Medewerkers en onderzoekers
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
- Endocriene systeemziekten
- Neoplasmata per site
- Neoplasmata
- Darmziekten
- Gastro-intestinale neoplasmata
- Neoplasmata van het spijsverteringsstelsel
- Ziekten van het spijsverteringsstelsel
- Gastro-intestinale aandoeningen
- Maag Ziekten
- Intestinale neoplasmata
- Rectale ziekten
- Endocriene klierneoplasmata
- Alvleesklier Ziekten
- Colon Ziekten
- Maagneoplasmata
- Colorectale neoplasmata
- Pancreasneoplasmata
Andere studie-ID-nummers
- KITuKo
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .